We had 15 patients on the March 5 PR and the trial started on Feb 22. That's about 1.3 patients per day. Increased sites and declining cases should roughly sustain that for us.
120/1.3 = ~92 days to finish recruitment and dosing.
+29 days to finish treatment course
+60 days to collect/collate/analyze data
~181 days total = ~6 months
Feb 22 + 6 months = mid August for results.
I would hope there is some room and rush to get this done sooner but that looks like a reasonable timeline by my estimate and the limited data we have. It also fits fairly well with the ABSSSI trial and other COVID trials (both Leronlimabs).
News 
Market Data 
Discover 
